{"ticker": {"uuid": "8151ad47-a915-4175-a114-14a8ea1d3a96", "symbol": "GUBRA", "name": "Gubra A/S", "exchange": "CPH", "country": "DK", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgJBVV95cUxNTVgxX1Fuc2VzNUh0a19KbzA2VDgtcTdsb1RBTUxQV19FOTl1dGZCSGZ0WVBad0FtWjlHLThoV0htZ2MweTk5a0hDWDNmbW1BN05zNHlaLVlkR094X1d6WmRHVzRQQzVxZ3ZoTG9FenczOVNBaURiTHRmam9LZ2tSREtSbGRfc0N1Y25JemFkZWtHQUg1RVpJNEN5VHU3bm9LSjlNZXU0WFA1dU8tQ190WURpRDEzZy13V0twdmJIMjg5d0tGaXZ0WXRHWmJpbEVDTTZvLVpXeEVXcEJGLUhvNUtTR0ZYQVQyb0NZYngyb0ExazA3Q0NwQ2RLOGwwWGFjMUlYbUtXbS1iTWE2Z0NKY0RlbzhYQWRSYkdOWXFMa1VXNHhhLUl6djZqQzhZajRxUXc?oc=5", "source_name": "TradingView", "published_at": "2026-06-17T21:29:00+00:00", "published_display": "17 Jun 2026 21:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gubra capital increase in connection with exercise of warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQQkVTenhuSzhYUXNYQTNydk0tSkFQbTNxNTZrLTJISjZiQXptWVV4X2hBSFo5SVRCS3VQTW9MSjVveEp2alBqNzB4VGh1blBNZEJpaDBSVXkyUFAyU1JycWxWR091Nk1TNW9maUdJWDBnLVBMNHRfNk41Z0VYbWhYRWFsS0JnNXBsN3lNOW1fTzYzQVQyNllfdXhrWXBlUktHbGxIQXg1Z1BITl95MDIweVhGNHhlNEM1VVBKWFJ2NEFkM0dMdjJR?oc=5", "source_name": "TradingView", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gubra initiates employee share matching program", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxObndST2xUcWNqQ09hQWRhSjZSNUNVdzNKZHRRYUg2di1tZU1zZ1V2RDQ2UlNlYjFwdjhCN1NkZmM4ai0tVXJ0NmV1TFhlM0xNU3l3RnpUaHN5SnJVcXZCTE5GT3JZVE5VQlJqMWQwN1h3NVl4Tlg5Q3k3czIwQXNabHpuVjZLRTl0MDNKSjVBYnRMdG1hb2dNNlM4eFI3ZGFHWHEwMWppZDRVejJNb2xxWXRBWQ?oc=5", "source_name": "TradingView", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gubra Q1 2026 slides: pipeline advances as CRO segment faces headwinds", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxObkhkbmFwb3NfbTZiejZ2Q3p1a052Q29iY0NCV2N3QmI4bElEdk1INk53cnl1NmVLMk5WRVlPOFI5WHBSYUEzMTBrN2otY3VIcjJKOVNYNDcxbk9XTzZTV3lQV3pLU0Q0dU1DaDUwQkpwUHMzUU1KZ3BjQk1UcThJa3podmJrOEVvQWF1UEhGaGhPREhYUGNfOU4yZzVYcXNIb1hQWjVJT1BDQ2FZa01ZU0ZuRVJnTVNnX050SUtteExrSk5q?oc=5", "source_name": "Investing.com", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gubra FY 2025 slides: $2.2bn AbbVie deal drives record results", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQNnZwbHJTWnZkUGVWNW9hclZOVkwtODN1QmJpNUNtRW1OYlhMYUJrbk1XQ1Vmem1yN0ttMUZsbDZqM2g2MlRlZFhPU3AyN2hzbXUzaWNlUUl4TWxuTGNrV21IR3M4RjRUSXQyWER6cFZZQ2FEY0xaRzhZWkZCdUhBNWZKM3dtY0dwR2hfLThJYXh2c1E4RWR5LTBOSlRoU1k3WGxtMHY0M1owRnl6QnpISW1OYTh3QTA?oc=5", "source_name": "Investing.com", "published_at": "2026-02-27T08:00:00+00:00", "published_display": "27 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gubra recruits former Novo Nordisk director as new CTO", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE04a1VhRGZueHhQbTE0ZElINkNPNWV2RjRNdDk4YnlIREJHcWxLbnNwa1lKRE1JX3JZZFgxQTYzVzBwOFl6VlF3SUlvRDU0ejVtOEdscXNwZlpuUVVXVTNFZ2lhWTM3TmNNNkJPY1M0d2NvOUo2UjVR?oc=5", "source_name": "medwatch.com", "published_at": "2026-02-16T08:00:00+00:00", "published_display": "16 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Whether Gubra (CPSE:GUBRA) Looks Undervalued After Recent Share Price Gains", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPXzRkUWM0MEoyMGRhWWJBQlc3WEhmeHN3cHBsaUNGMGJkTEV2ZV9aYzh5bnJqaUc1Sk1SWEN2dGRTc3gzRXdhb3AydVg2UHotdjRRLUJadENkR012YkFiTnZDYU5iM1FFOXdwYzF2cm5SX2lSRTJwREFyaDE4TjQ5T3hFVzc4Rnc?oc=5", "source_name": "Market source", "published_at": "2026-01-22T08:00:00+00:00", "published_display": "22 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Gubra CEO purchases shares worth DKK 1.6m", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE93ZHJ0S1VDbUJsT2JmS3c5VWZwUjRWeXhPdEpGYmlsNE5udHFja2NMUTF5WmVKOHI0b3dndGlRMGJsNUpTc19MMzljUXFYTnJPbTBvUXdULTE4LWJYc2pwd0Z2bzZlMnl6enNXejlkaw?oc=5", "source_name": "medwatch.com", "published_at": "2025-11-10T08:00:00+00:00", "published_display": "10 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gubra H1 2025 slides: AbbVie deal drives record revenue, GUBamy shows strong results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxOeU5rY0taRi1HMVlIODlfOGgtdFJ4N0Z3VGZhel92WkFGWFhPRnA2azNpYkdEMW95MFlqNm5jNVJ5VjhYOVRHUHNFaVgzeWYtQU02bG9aMzIwOVN0YmVsbFRwaDBUREljMl9xX3FyQmVUSDBDS0hZa2NVNWgzOUhZRnNRd0JSUkd2b2RacjBIMEstdjVYd29ZMWxuUzV3TkZ5UThGYWVZalNCSmhBa2JrX0RpUUVLdEdpcnMtQ3ZGaXhUbXBlVHpWQmpmaldkQ2tCbVdidE9B?oc=5", "source_name": "Investing.com", "published_at": "2025-08-21T07:00:00+00:00", "published_display": "21 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gubra appoints a new chief executive", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYEFVX3lxTE9XamlWS1N4OWcyQk12MXhIU0tlSXNvaW9Pc2hkT0g0YzZkNXVpN0J1WEh0WE9TbWo0Z2xZejloMFRGeERIQmNpbEVnNGdlSGQ3SWctQVlncnhRaWJ2UGpzdg?oc=5", "source_name": "medwatch.com", "published_at": "2025-08-12T07:00:00+00:00", "published_display": "12 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GUBRA A/S To Go Ex-Dividend On June 30th, 2025 With 9.22895 USD Special Dividend Per Share", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNRjN3OUZUWTVvNXVEVVBQLWRHVkFXRlUxdmNITldsLV9EU1Jmdi1UYnMtLVl0X09KMV82LWlDRWFXSi1XRjcyQVlKVC0yY0VJM3ZpLUtmalM5anJrMnlMMDlwSnA0cHMtcVk0U3dmWF9fUnZwV1BLU244UHRvMzhMa19fMWp5ZXFEalE?oc=5", "source_name": "Moomoo", "published_at": "2025-06-26T07:00:00+00:00", "published_display": "26 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AbbVie enters obesity space with $2.3bn Gubra deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPRk1JSjBCd05yUGpIS0NYR1VqV3ZrSmQtSDdVU1gwZ1NRNzRUbjB6QTBWTlNVbFpZLUtqNmJsS0JLd1lIeURnZTFaQXB4eW5oUnBxS2lGaUlzV3dSR0FtbGJUbHY2Q3Uyc3JDSTVWaFhzX3JibEl1UTlaTGxxSFNFM2FwVFJxN1FkVGdPZ2ZVYWNrNkZlNWpxaTBweF9aUQ?oc=5", "source_name": "Pharmaceutical Technology", "published_at": "2025-03-03T08:00:00+00:00", "published_display": "03 Mar 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AbbVie and Gubra in billion-dollar deal for new obesity treatment", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNTGVock1BZXdiSVJZUHF5dlFEcldPaWR1MUNWNkxlUnhIb2FqUG9DZTliWEdoZ2RORXliZUt1QlA5RV9kaVF6U3JYTjYyRklWaXV3V2plODlWSEdMVTE4dnhRUUVKajhkY0RObHBpNHFlTTRROE5MWU9WeF9JZGZxcDdnMlVQSEhyX2hCMllWUQ?oc=5", "source_name": "Biostock", "published_at": "2025-03-03T08:00:00+00:00", "published_display": "03 Mar 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GUBRA Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "", "url": "https://news.google.com/rss/articles/CBMiakFVX3lxTE1jYVM4VGFZZjlFQlNEV3I5QzRRamNMalY2dGZndnQ5T0tCdE1CVFlaYUxGR0dnRk9OTll6R1BNUGhWSWVyQUJlM2xnWDlTaEVtS3gycFRIYzJVbDk0em11UEZnamNvNHpXVkE?oc=5", "source_name": "TradingView", "published_at": "2024-04-04T09:19:35+00:00", "published_display": "04 Apr 2024 09:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GUBRA Stock Price and Chart \u2014 OMXCOP:GUBRA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXkFVX3lxTE9fXzhDMnZFaHJXVXhEUUR4RUc0Z0xXY0hRbWx5QzBLMTlFUXo2XzVhNnR3NGt4MHVGcDdGdFp3bS1JU2gzUzEycDFFLXRnWFhyWk5yVmdNZnlXTzNWR1E?oc=5", "source_name": "TradingView", "published_at": "2024-03-04T08:00:00+00:00", "published_display": "04 Mar 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gubra A/S: Shareholders Board Members Managers and Company Profile | DK0062266474", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTFBTSVhFdjVONTZXM1ZfS1pOSTlUcW1VMUs0QVZLSUNaZXdJaHRhNWlfaVpvM1B5a0xzQzRGNFV2V25CVExkQUx6SUtWaFN6Zm9hNFFBblotVWNLM3VGclNsdzZTcklHXzNPZ1Rhd1BIOURVU2p3RWRiaTR3QQ?oc=5", "source_name": "marketscreener.com", "published_at": "2023-04-07T21:48:34+00:00", "published_display": "07 Apr 2023 21:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Gubra A/S (OMXCOP:GUBRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE54RkpWZlJzc2J1MFZKdEo5M0liZlFsUlhITWhMTTBnX281dWlrQlFHVUM0Rml1N2xyTEM3ZTFEMGM5VndNOW15Y0Z3VXItTElmcEdfVUxIV2ZMaFd5WUhiazdrVWxhQTBPQkJOVQ?oc=5", "source_name": "TradingView", "published_at": "2023-04-05T05:35:27+00:00", "published_display": "05 Apr 2023 05:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgJBVV95cUxNTVgxX1Fuc2VzNUh0a19KbzA2VDgtcTdsb1RBTUxQV19FOTl1dGZCSGZ0WVBad0FtWjlHLThoV0htZ2MweTk5a0hDWDNmbW1BN05zNHlaLVlkR094X1d6WmRHVzRQQzVxZ3ZoTG9FenczOVNBaURiTHRmam9LZ2tSREtSbGRfc0N1Y25JemFkZWtHQUg1RVpJNEN5VHU3bm9LSjlNZXU0WFA1dU8tQ190WURpRDEzZy13V0twdmJIMjg5d0tGaXZ0WXRHWmJpbEVDTTZvLVpXeEVXcEJGLUhvNUtTR0ZYQVQyb0NZYngyb0ExazA3Q0NwQ2RLOGwwWGFjMUlYbUtXbS1iTWE2Z0NKY0RlbzhYQWRSYkdOWXFMa1VXNHhhLUl6djZqQzhZajRxUXc?oc=5", "source_name": "TradingView", "published_at": "2026-06-17T21:29:00+00:00", "published_display": "17 Jun 2026 21:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gubra capital increase in connection with exercise of warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQQkVTenhuSzhYUXNYQTNydk0tSkFQbTNxNTZrLTJISjZiQXptWVV4X2hBSFo5SVRCS3VQTW9MSjVveEp2alBqNzB4VGh1blBNZEJpaDBSVXkyUFAyU1JycWxWR091Nk1TNW9maUdJWDBnLVBMNHRfNk41Z0VYbWhYRWFsS0JnNXBsN3lNOW1fTzYzQVQyNllfdXhrWXBlUktHbGxIQXg1Z1BITl95MDIweVhGNHhlNEM1VVBKWFJ2NEFkM0dMdjJR?oc=5", "source_name": "TradingView", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gubra initiates employee share matching program", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxObndST2xUcWNqQ09hQWRhSjZSNUNVdzNKZHRRYUg2di1tZU1zZ1V2RDQ2UlNlYjFwdjhCN1NkZmM4ai0tVXJ0NmV1TFhlM0xNU3l3RnpUaHN5SnJVcXZCTE5GT3JZVE5VQlJqMWQwN1h3NVl4Tlg5Q3k3czIwQXNabHpuVjZLRTl0MDNKSjVBYnRMdG1hb2dNNlM4eFI3ZGFHWHEwMWppZDRVejJNb2xxWXRBWQ?oc=5", "source_name": "TradingView", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gubra Q1 2026 slides: pipeline advances as CRO segment faces headwinds", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxObkhkbmFwb3NfbTZiejZ2Q3p1a052Q29iY0NCV2N3QmI4bElEdk1INk53cnl1NmVLMk5WRVlPOFI5WHBSYUEzMTBrN2otY3VIcjJKOVNYNDcxbk9XTzZTV3lQV3pLU0Q0dU1DaDUwQkpwUHMzUU1KZ3BjQk1UcThJa3podmJrOEVvQWF1UEhGaGhPREhYUGNfOU4yZzVYcXNIb1hQWjVJT1BDQ2FZa01ZU0ZuRVJnTVNnX050SUtteExrSk5q?oc=5", "source_name": "Investing.com", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gubra FY 2025 slides: $2.2bn AbbVie deal drives record results", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQNnZwbHJTWnZkUGVWNW9hclZOVkwtODN1QmJpNUNtRW1OYlhMYUJrbk1XQ1Vmem1yN0ttMUZsbDZqM2g2MlRlZFhPU3AyN2hzbXUzaWNlUUl4TWxuTGNrV21IR3M4RjRUSXQyWER6cFZZQ2FEY0xaRzhZWkZCdUhBNWZKM3dtY0dwR2hfLThJYXh2c1E4RWR5LTBOSlRoU1k3WGxtMHY0M1owRnl6QnpISW1OYTh3QTA?oc=5", "source_name": "Investing.com", "published_at": "2026-02-27T08:00:00+00:00", "published_display": "27 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gubra recruits former Novo Nordisk director as new CTO", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE04a1VhRGZueHhQbTE0ZElINkNPNWV2RjRNdDk4YnlIREJHcWxLbnNwa1lKRE1JX3JZZFgxQTYzVzBwOFl6VlF3SUlvRDU0ejVtOEdscXNwZlpuUVVXVTNFZ2lhWTM3TmNNNkJPY1M0d2NvOUo2UjVR?oc=5", "source_name": "medwatch.com", "published_at": "2026-02-16T08:00:00+00:00", "published_display": "16 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Whether Gubra (CPSE:GUBRA) Looks Undervalued After Recent Share Price Gains", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPXzRkUWM0MEoyMGRhWWJBQlc3WEhmeHN3cHBsaUNGMGJkTEV2ZV9aYzh5bnJqaUc1Sk1SWEN2dGRTc3gzRXdhb3AydVg2UHotdjRRLUJadENkR012YkFiTnZDYU5iM1FFOXdwYzF2cm5SX2lSRTJwREFyaDE4TjQ5T3hFVzc4Rnc?oc=5", "source_name": "Market source", "published_at": "2026-01-22T08:00:00+00:00", "published_display": "22 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Gubra CEO purchases shares worth DKK 1.6m", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE93ZHJ0S1VDbUJsT2JmS3c5VWZwUjRWeXhPdEpGYmlsNE5udHFja2NMUTF5WmVKOHI0b3dndGlRMGJsNUpTc19MMzljUXFYTnJPbTBvUXdULTE4LWJYc2pwd0Z2bzZlMnl6enNXejlkaw?oc=5", "source_name": "medwatch.com", "published_at": "2025-11-10T08:00:00+00:00", "published_display": "10 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gubra H1 2025 slides: AbbVie deal drives record revenue, GUBamy shows strong results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxOeU5rY0taRi1HMVlIODlfOGgtdFJ4N0Z3VGZhel92WkFGWFhPRnA2azNpYkdEMW95MFlqNm5jNVJ5VjhYOVRHUHNFaVgzeWYtQU02bG9aMzIwOVN0YmVsbFRwaDBUREljMl9xX3FyQmVUSDBDS0hZa2NVNWgzOUhZRnNRd0JSUkd2b2RacjBIMEstdjVYd29ZMWxuUzV3TkZ5UThGYWVZalNCSmhBa2JrX0RpUUVLdEdpcnMtQ3ZGaXhUbXBlVHpWQmpmaldkQ2tCbVdidE9B?oc=5", "source_name": "Investing.com", "published_at": "2025-08-21T07:00:00+00:00", "published_display": "21 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gubra appoints a new chief executive", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYEFVX3lxTE9XamlWS1N4OWcyQk12MXhIU0tlSXNvaW9Pc2hkT0g0YzZkNXVpN0J1WEh0WE9TbWo0Z2xZejloMFRGeERIQmNpbEVnNGdlSGQ3SWctQVlncnhRaWJ2UGpzdg?oc=5", "source_name": "medwatch.com", "published_at": "2025-08-12T07:00:00+00:00", "published_display": "12 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GUBRA A/S To Go Ex-Dividend On June 30th, 2025 With 9.22895 USD Special Dividend Per Share", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNRjN3OUZUWTVvNXVEVVBQLWRHVkFXRlUxdmNITldsLV9EU1Jmdi1UYnMtLVl0X09KMV82LWlDRWFXSi1XRjcyQVlKVC0yY0VJM3ZpLUtmalM5anJrMnlMMDlwSnA0cHMtcVk0U3dmWF9fUnZwV1BLU244UHRvMzhMa19fMWp5ZXFEalE?oc=5", "source_name": "Moomoo", "published_at": "2025-06-26T07:00:00+00:00", "published_display": "26 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AbbVie enters obesity space with $2.3bn Gubra deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPRk1JSjBCd05yUGpIS0NYR1VqV3ZrSmQtSDdVU1gwZ1NRNzRUbjB6QTBWTlNVbFpZLUtqNmJsS0JLd1lIeURnZTFaQXB4eW5oUnBxS2lGaUlzV3dSR0FtbGJUbHY2Q3Uyc3JDSTVWaFhzX3JibEl1UTlaTGxxSFNFM2FwVFJxN1FkVGdPZ2ZVYWNrNkZlNWpxaTBweF9aUQ?oc=5", "source_name": "Pharmaceutical Technology", "published_at": "2025-03-03T08:00:00+00:00", "published_display": "03 Mar 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AbbVie and Gubra in billion-dollar deal for new obesity treatment", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNTGVock1BZXdiSVJZUHF5dlFEcldPaWR1MUNWNkxlUnhIb2FqUG9DZTliWEdoZ2RORXliZUt1QlA5RV9kaVF6U3JYTjYyRklWaXV3V2plODlWSEdMVTE4dnhRUUVKajhkY0RObHBpNHFlTTRROE5MWU9WeF9JZGZxcDdnMlVQSEhyX2hCMllWUQ?oc=5", "source_name": "Biostock", "published_at": "2025-03-03T08:00:00+00:00", "published_display": "03 Mar 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GUBRA Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "", "url": "https://news.google.com/rss/articles/CBMiakFVX3lxTE1jYVM4VGFZZjlFQlNEV3I5QzRRamNMalY2dGZndnQ5T0tCdE1CVFlaYUxGR0dnRk9OTll6R1BNUGhWSWVyQUJlM2xnWDlTaEVtS3gycFRIYzJVbDk0em11UEZnamNvNHpXVkE?oc=5", "source_name": "TradingView", "published_at": "2024-04-04T09:19:35+00:00", "published_display": "04 Apr 2024 09:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GUBRA Stock Price and Chart \u2014 OMXCOP:GUBRA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXkFVX3lxTE9fXzhDMnZFaHJXVXhEUUR4RUc0Z0xXY0hRbWx5QzBLMTlFUXo2XzVhNnR3NGt4MHVGcDdGdFp3bS1JU2gzUzEycDFFLXRnWFhyWk5yVmdNZnlXTzNWR1E?oc=5", "source_name": "TradingView", "published_at": "2024-03-04T08:00:00+00:00", "published_display": "04 Mar 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gubra A/S: Shareholders Board Members Managers and Company Profile | DK0062266474", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTFBTSVhFdjVONTZXM1ZfS1pOSTlUcW1VMUs0QVZLSUNaZXdJaHRhNWlfaVpvM1B5a0xzQzRGNFV2V25CVExkQUx6SUtWaFN6Zm9hNFFBblotVWNLM3VGclNsdzZTcklHXzNPZ1Rhd1BIOURVU2p3RWRiaTR3QQ?oc=5", "source_name": "marketscreener.com", "published_at": "2023-04-07T21:48:34+00:00", "published_display": "07 Apr 2023 21:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Gubra A/S (OMXCOP:GUBRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE54RkpWZlJzc2J1MFZKdEo5M0liZlFsUlhITWhMTTBnX281dWlrQlFHVUM0Rml1N2xyTEM3ZTFEMGM5VndNOW15Y0Z3VXItTElmcEdfVUxIV2ZMaFd5WUhiazdrVWxhQTBPQkJOVQ?oc=5", "source_name": "TradingView", "published_at": "2023-04-05T05:35:27+00:00", "published_display": "05 Apr 2023 05:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 73, "total_relevant": 17, "sentiment_summary": {"positive": 3, "negative": 0, "neutral": 14, "score": 54, "total": 17, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 6.05, "count": 11}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 3, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 337.8, "latest_week": "2026-06-19", "one_week_move": -6.5, "four_week_move": -0.6, "twelve_week_move": -5.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.267107, "market_dynamics_buy_signal": false, "relative_strength": -18.005, "fair_value_gap": -2.1, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 50.3951, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-6.5% over one week, -0.6% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 64, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 6}, {"label": "Investing.com", "count": 3}, {"label": "medwatch.com", "count": 3}, {"label": "Market source", "count": 1}, {"label": "Moomoo", "count": 1}, {"label": "Pharmaceutical Technology", "count": 1}, {"label": "Biostock", "count": 1}, {"label": "marketscreener.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 17}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 11}, {"label": "Earnings", "count": 2}, {"label": "Deals and strategy", "count": 2}, {"label": "Capital return", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "17", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-6.5% over one week, -0.6% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares"}], "updated_at": "2026-06-23T05:06:44.902099+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}